Abstract

Objective: Multifocal motor neuropathy (MMN) is a rare inflammatory neuropathy, clinically characterized by exclusive motor involvement. We wished to evaluate the possible presence of sensory dysfunction, including the evaluation of small fibres, after a long-term disease course. Patients and methods: seven MMN patients, regularly followed in our Neurology Department, underwent clinical evaluation, neurophysiological examination by nerve conduction studies (NCSs), and Sudoscan. We compared neurophysiological data with a group of patients with other disorders of the peripheral nervous system. Results: NCSs showed a reduction of sensory nerve action potential amplitude in 2/7 MMN patients. Sudoscan showed borderline electrochemical skin conductance (ESC) values in 3/7 MMN patients (two of them with abnormal sensory NCSs). Conclusions: Our results confirm that sensory involvement may be found in some MMN after a long-term disease course, and it could also involve the small fibres.

Highlights

  • Multifocal motor neuropathy (MMN) is a rare disorder in which focal areas of multiple motor nerves are attacked by one’s own immune system [1,2,3]

  • In this study, we examined a cohort of MMN patients, regularly followed in our department, in order to investigate the possible presence of small fibre dysfunction after a long-term disease course by the use of Sudoscan

Read more

Summary

Introduction

MMN (multifocal motor neuropathy) is a rare disorder in which focal areas of multiple motor nerves are attacked by one’s own immune system [1,2,3]. Antibodies to ganglioside GM1 are reported in 40–85% of cases [4,5,6,7]. MMN is a slowly progressive disorder, resulting in asymmetric limb weakness; patients frequently develop weakness in their hand(s), resulting in dropping of objects or sometimes inability to turn a key in a lock. The weakness associated with MMN can be recognized as fitting a specific nerve territory. Corticosteroids and plasma exchange are not effective, while treatment with intravenous immunoglobulin (IVIg) and/or cyclophosphamide generally delays or stops disease progression [8,9,10,11]

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.